Corona Vaccine News: COVID-19 Vaccine Update

Corona Vaccine News: Government wants to order the first order of 50 lakh doses of COVID-19 vaccine

Corona Vaccine India, corona vaccine kab aayegi: Even though the Corona vaccine is not ready in the country yet, the government has started further preparations. At the beginning, who is going to get the vaccine, price, etc. are in talks with the companies. Meanwhile, information has emerged regarding the first batch.

 

The Indian government is initially contemplating buying about 5 million doses of the Corona vaccine against Corona for advance personnel, army personnel, and certain categories of people. After the approval of the vaccine, there is a churn in the government regarding the priorities of making it available. The focus is on supply chain and distribution. A framework is being created to provide the vaccine to the employees on the front and those at the highest risk.

 

The Government wants to distribute the vaccine on a large scale so that it can reach the larger population at the earliest. Official sources said that the local vaccine manufacturers have asked the government to give estimates of a certain market as a shot will be ready within a few weeks once the vaccine is made. Companies have been assured of vaccine demand. It is believed that a vaccine may be ready later this year or early next year.

During a meeting with major vaccine manufacturers on Monday, an expert group on the Kovid vaccine has asked companies to make their proposals, asking for production capacity information, pricing, and suggestions on how the government can support them. The group is also headed by NITI Aayog member VK Paul and Health Secretary Rajesh Bhushan.

A senior executive of a local vaccine manufacturer said, "We have to invest heavily in the development of the vaccine and we have to put our capacity to increase production of the Kovid-19 vaccine." In such a situation, the government must give a hint about a certain market.

The official said that the expert group is considering various options including financial assistance for the production of the vaccine if necessary. However, the discussion is still in the initial stage and before reaching a plan, the committee may hold a few more meetings.

Suggestions have been sought from the Standing Technical Sub-Committee of the National Technical Advisory Group on Immunization (stage), the top advisory body on vaccine, regarding the selection of vaccine candidates.

 

At present, a human trial of three vaccines is going on in India. Bharat Biotech-ICMR's Covaxin and Zydus Cadila's ZyCov-D are currently in Phase 1/2 trials. Apart from this, Serum Institute of India (SII) has also done a trial of AstraZeneca for the AZD1222 vaccine. The vaccine candidates the government panel is looking at include Oxford-AstraZeneca and Moderna in Phase 3 trials.

Apart from this, the government is also considering nine more vaccine programs including Germany and Israel. On Monday, when the National Expert Group on Vaccine The administration met, it included heads of several pharma companies besides SII, Bharat Biotech and Zydus Cadila.